🔎 Trials Near Me

Akèy › Timè nan sèvo

Etid klinik pou Timè nan sèvo ap rekrite nan Etazini

198 etid pou Timè nan sèvo ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma

Ap rekriteFaz 1
Laj 21 a 70 · Tout sèks · Mizajou Sep 30, 2026 · NCT06815432

Evaluation and Treatment of Neurosurgical Disorders

Ap rekriteEtid obsèvasyon
Laj 4 a 99 · Tout sèks · Mizajou Sep 29, 2026 · NCT00060541

Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures

Ap rekriteFaz 1/2
6 Months – 25 Years · Tout sèks · Mizajou Sep 29, 2026 · NCT04085887

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Ap rekriteFaz 1/2
Laj 18 a 99 · Tout sèks · Mizajou Sep 28, 2026 · NCT07416188

SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT04923542

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07326566

C-SMART vs BE Well for Patients With Brain Tumors

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07224503

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379

RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)

Ap rekriteFaz 1
Laj 18 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT06389591

Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT05733312

Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07470606

Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07248228

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT04977375

REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07831772

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

Ap rekriteFaz 1 bonè
Laj 18 a 99 · Tout sèks · Mizajou Sep 21, 2026 · NCT06055790

Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07053033

PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07827001

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07227610

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924

Development of MRF for Characterization of Brain Tumors After Radiotherapy

Ap rekriteVolontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Sep 15, 2026 · NCT06101069

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Ap rekriteFaz 2
59 Months · Tout sèks · Mizajou Sep 15, 2026 · NCT05535166

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.